Literature DB >> 33734429

Neurological symptoms and blood neurofilament light levels.

Christian Barro1,2, Henrik Zetterberg3,4,5,6.   

Abstract

Neurofilament light chain (NfL) is an incredibly specific marker of neuronal injury that is not specific for cause or location of the neuronal damage. NfL is increasingly considered as possible biomarker of disease activity in neurological conditions. Several works reviewed the utility of NfL in the different diseases. Nonetheless, NfL is a universal marker of neuronal damage, which interpretation spaces beyond the single disease. Because of this, the interpretation of NfL may benefit by also considering how neurological symptoms relate to its blood concentration. Here, we review how different neurological symptoms can be associated with blood NfL levels with a practical interpretation of it.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  biomarker; neurofilament; neurologic disease

Mesh:

Substances:

Year:  2021        PMID: 33734429     DOI: 10.1111/ane.13415

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  5 in total

Review 1.  Promising Blood Biomarkers for Clinical Use in Alzheimer's Disease: A Focused Update.

Authors:  Sun Ah Park; Yu Jung Jang; Min Kyoung Kim; Sun Min Lee; So Young Moon
Journal:  J Clin Neurol       Date:  2022-07       Impact factor: 2.566

Review 2.  An Update on the Measurement of Motor Cerebellar Dysfunction in Multiple Sclerosis.

Authors:  Katherine Hope Kenyon; Frederique Boonstra; Gustavo Noffs; Helmut Butzkueven; Adam P Vogel; Scott Kolbe; Anneke van der Walt
Journal:  Cerebellum       Date:  2022-06-27       Impact factor: 3.648

3.  Neurological Involvement in COVID-19 Among Non-Hospitalized Adolescents and Young Adults.

Authors:  Lise Beier Havdal; Lise Lund Berven; Joel Selvakumar; Tonje Stiansen-Sonerud; Truls Michael Leegaard; Trygve Tjade; Henrik Zetterberg; Kaj Blennow; Vegard Bruun Bratholm Wyller
Journal:  Front Neurol       Date:  2022-06-22       Impact factor: 4.086

4.  Modulation of the Thrombin Pathway Restores LTP in a Pilocarpine Mice Model of Status Epilepticus.

Authors:  Efrat Shavit-Stein; Shani Berkowitz; Tal Davidy; Uri Fennig; Shani Guly Gofrit; Amir Dori; Nicola Maggio
Journal:  Front Cell Neurosci       Date:  2022-05-24       Impact factor: 6.147

5.  Serum neurofilament light protein correlates with unfavorable clinical outcomes in hospitalized patients with COVID-19.

Authors:  Mercedes Prudencio; Young Erben; Christopher P Marquez; Karen R Jansen-West; Camila Franco-Mesa; Michael G Heckman; Launia J White; Judith A Dunmore; Casey N Cook; Meredith T Lilley; Yuping Song; Caroline F Harlow; Björn Oskarsson; Katharine A Nicholson; Zbigniew K Wszolek; LaTonya J Hickson; John C O'Horo; Jonathan B Hoyne; Tania F Gendron; James F Meschia; Leonard Petrucelli
Journal:  Sci Transl Med       Date:  2021-06-15       Impact factor: 17.956

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.